Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 9397 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Table of Contents
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal

Year : 1992  |  Volume : 34  |  Issue : 3  |  Page : 260-263

Clinical Efficacy of Centporpazine a New Antidepressant

1 Central Drug Research Institute, Lucknow, India
2 Former Head, Department of Psychiatry, R.M.L. Hospital, New Delhi, India
3 Former Professor & Head, Department of Psychiatry, Seth G.S. Medical College, Bombay, India
4 Former Professor & Head, Department of Psychiatry, K.G's Medical College, Lucknow, India
5 Professor & Head, Department of Psychiatry, Govt. Medical College, Patiala, India

Correspondence Address:
R C Srimal
Senior Deputy Director & Head, Division of Clinical Pharmacology, Central Drug Research Institute, Lucknow
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 21776129

Rights and PermissionsRights and Permissions

Efficacy of centpropazine, a new antidepressant, has been evaluated in forty two patients of endogenous depression. The 4 week open trial was carried out in a dose-range of 40 to 120mg per day. A significant lowering of Hamilton Depression Rating Scale (HDRS) score was observed in 34 patient. The antidepressant effect could be detected in 9 patients within one week, in 28 cases in two weeks and in all the 34 patients by third week. Giddiness, headache, dryness of mouth and weakness were reported by 11 patients.



Print this article         Email this article